Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients

Creative Commons License

Atabey R. D., Aladağ N., Sipal A., Akbulut T., Dogan Z., Ozdemir M.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, cilt.68, sa.2, ss.176-182, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 68 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1590/1806-9282.20210887
  • Dergi Adı: REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.176-182
  • Anahtar Kelimeler: COVID-19, Cardiovascular drugs, Potential risk factors, Renal failure, Intubation
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

OBJECTIVES: Cardiovascular diseases are also considered to increase the risk of death in COVID-19 patients. However, real-world data concerning the risk factors for death in patients with severe COVID-19 still remain vague. This study aimed to identify the potential risk factors associated with mortality in severe COVID-19 patients.